Author
Listed:
- Nikita Sushentsev
(Addenbrooke’s Hospital and University of Cambridge)
- Mary A. McLean
(Addenbrooke’s Hospital and University of Cambridge
University of Cambridge)
- Anne Y. Warren
(Cambridge University Hospitals NHS Foundation Trust)
- Arnold J. V. Benjamin
(Addenbrooke’s Hospital and University of Cambridge)
- Cara Brodie
(University of Cambridge)
- Amy Frary
(Addenbrooke’s Hospital and University of Cambridge)
- Andrew B. Gill
(Addenbrooke’s Hospital and University of Cambridge)
- Julia Jones
(University of Cambridge)
- Joshua D. Kaggie
(Addenbrooke’s Hospital and University of Cambridge)
- Benjamin W. Lamb
(Cambridge University Hospitals NHS Foundation Trust
Anglia Ruskin University)
- Matthew J. Locke
(Addenbrooke’s Hospital and University of Cambridge)
- Jodi L. Miller
(University of Cambridge)
- Ian G. Mills
(Queen’s University Belfast
University of Oxford, John Radcliffe Hospital
University of Bergen
University of Bergen)
- Andrew N. Priest
(Addenbrooke’s Hospital and University of Cambridge)
- Fraser J. L. Robb
(GE Healthcare)
- Nimish Shah
(Cambridge University Hospitals NHS Foundation Trust)
- Rolf F. Schulte
(GE Healthcare)
- Martin J. Graves
(Addenbrooke’s Hospital and University of Cambridge)
- Vincent J. Gnanapragasam
(Cambridge University Hospitals NHS Foundation Trust
University of Cambridge
Cambridge Urology Translational Research and Clinical Trials Office, Cambridge Biomedical Campus, Addenbrooke’s Hospital)
- Kevin M. Brindle
(University of Cambridge
University of Cambridge)
- Tristan Barrett
(Addenbrooke’s Hospital and University of Cambridge)
- Ferdia A. Gallagher
(Addenbrooke’s Hospital and University of Cambridge)
Abstract
No abstract is available for this item.
Suggested Citation
Nikita Sushentsev & Mary A. McLean & Anne Y. Warren & Arnold J. V. Benjamin & Cara Brodie & Amy Frary & Andrew B. Gill & Julia Jones & Joshua D. Kaggie & Benjamin W. Lamb & Matthew J. Locke & Jodi L. , 2022.
"Author Correction: Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer,"
Nature Communications, Nature, vol. 13(1), pages 1-1, December.
Handle:
RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-28979-1
DOI: 10.1038/s41467-022-28979-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-28979-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.